Clinical Trial Update: Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study comparing celecoxib to observation after chemoradiation in stage II/III non-small cell lung cancer, with no res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN